TOKYO -- Japanese pharmaceutical company Eisai will set up a joint venture with Chinese e-commerce group JD.com to launch an online medical services business focusing on dementia in China early next year, Nikkei has learned.
JD.com will have a 51% stake in the joint venture, with Eisai taking the rest. The Japanese drugmaker hopes to develop new dementia drugs targeted at China's growing number of elderly people, based on big medical data that it expects to gather from the new service.
